Speed & Scale in the Great Disruption. As we worked with providers, innovators and experts around the world to understand the trends most likely to drive change in life science clinical and commercial engagement, twenty quickly stood out.
Read MoreIn a time of deep unrest amid significant social and health inequity, life sciences leaders are confronting calls to address systemic racism and inequities in the biopharmaceutical industry.
Read ArticleThat healthcare is somehow its own thing, separate and distinct from a customer’s bigger world and cultural context, was for a long time taken for granted. Its lab-borne products are complex, often life-saving creations. They’re the stuff of doctor’s offices and hospitals.
Read ArticleReport November 18, 2022
As we enter what the 2022 HBA European Leadership Summit refers to as the “Innovation Age,” we are constantly surrounded by something—anything—new. If it’s not new, it’s not relevant. And while that isn’t necessarily true, this is: change is constant.
Report December 21, 2021
After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer.
Report September 9, 2021
The evolving challenges of the American physician as they emerge from the pandemic
Report June 17, 2021
That healthcare is somehow its own thing, separate and distinct from a customer’s bigger world and cultural context, was for a long time taken for granted. Its lab-borne products are complex, often life-saving creations. They’re the stuff of doctor’s offices and hospitals.
Report March 5, 2021
Syneos Health conducted three surveys during the months of March and May 2020, and February 2021, to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.
Report February 9, 2021
President Joe Biden hit the ground running, signing 30 executive orders on healthcare. We can expect the focus on healthcare to continue, including speeding up vaccinations across the country and passing a new stimulus package as the first order of legislative business.
Report December 21, 2020
COVID-19 not only has changed the landscape of work but is continuing to metamorphose, requiring a near-constant adaptation to what has been dubbed the “new normal.”
Report December 11, 2020
Abby Purdy at Syneos Health Communications shares her perspective in this article on PMLiVE: "It’s hard to write a piece about digital innovation in the current climate without making reference to COVID-19 and the developments that the virus has accelerated and enforced."
Report December 1, 2020
Speed & Scale in the Great Disruption. As we worked with providers, innovators and experts around the world to understand the trends most likely to drive change in life science clinical and commercial engagement, twenty quickly stood out.
Report November 30, 2020
In a time of deep unrest amid significant social and health inequity, life sciences leaders are confronting calls to address systemic racism and inequities in the biopharmaceutical industry.
Report September 4, 2020
Our 10th annual trends report came out just over six months ago— in what may now feel like a distant world.
Report August 27, 2020
The practice of medicine has been radically disrupted in recent years by technology, consolidation and changing expectations… not to mention a worldwide pandemic.
Report August 5, 2020
Syneos Health surveyed 55 dermatologists to help us track and understand the impact COVID-19 has had on their engagement with telemedicine platforms and field force teams.
Report June 22, 2020
As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.
Report June 19, 2020
Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.
Report June 5, 2020
COVID-19 has introduced an era of unprecedented events to industries across the globe. In healthcare, marketers, patients and healthcare professionals alike are continuing to navigate and adjust to a new, virtual reality where our health needs are being serviced digitally.
Report May 14, 2020
Precision medicine. Value-based care. Intricate treatment protocols requiring detailed explanation and approval. In many ways, community oncologists have never needed stronger partnerships with life science innovators more than they do today.
Report May 7, 2020
Check out this installment of The MM&M Podcast with Kathleen Starr, PhD, Managing Director, Behavioral Science and Insights at Syneos Health.
Report May 6, 2020
Part I of a Syneos Health Series on New Oncology Commercialization Strategies
Report May 6, 2020
The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development. Artificial intelligence (AI) methods hold particular promise in helping to realise those efficiencies.
Report April 24, 2020
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Report April 23, 2020
Virtual collaboration isn’t the future of work – it's the wave of the present
Report April 22, 2020
Life sciences commercialization in the COVID-19 era and beyond
Report April 21, 2020
How are payers responding to COVID-19? Our team at Syneos Health Value and Access talked to 20 pharmacy and medical directors representing national and regional payers, insurers, IDNs, and hospitals.
Report April 21, 2020
Recommendations for activities to inform and engage
Report April 21, 2020
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
Report April 17, 2020
Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.
Report April 17, 2020
In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic. But what is the impact on the commercial side?
Report April 17, 2020
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
Report April 16, 2020
What should the evolution of your digital strategy look like through COVID-19 and beyond? Short and long term strategic approaches to differentiate and “reset” given the new normal.
Report April 14, 2020
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
Report April 13, 2020
Four Rapid Response Approaches To Maintain Business Momentum
Report April 9, 2020
Think Bank is an agile way to answer complex questions. It pairs a rapid learning cycle with a collaborative workshop both in person and in a virtual environment.
Report April 7, 2020
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
Report March 30, 2020
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
Report March 27, 2020
Payer perspectives on reimbursement hurdles can help DTx companies map the journey to real-world utilization and market success.
Report March 25, 2020
Often life sciences marketers must work with less than perfect insights when devising their channel strategies. Want to learn how to improve success rate by applying “Design Thinking” in multichannel marketing?
Report March 19, 2020
Virtual delivery requires you to rethink your content and approaches. Through the many successful online meetings we’ve run, we’ve learned how to help make your virtual meeting a success.
Report March 18, 2020
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries. COVID-19 has created uncertainty, unparalleled business disruptions and shaken up the global workforce.
Report March 17, 2020
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
Report March 16, 2020
Syneos Health Value & Access surveyed pharmacy and medical directors responsible for more than 100 million lives. We talked to national and regional payers, insurers, IDNs and hospitals to get a complete picture of key challenges, unmet needs and information sources.
Report February 7, 2020
Vanela Bushi (Director, Portfolio & Transaction Strategy) discusses one of the Trends 2020 - blockchain as a source of trust. Available in the latest edition of PharmaTimes magazine.
Report February 5, 2020
The point of care has been steadily shifting away from where the clinic exists to wherever the patient goes. Listen to this Syneos Health podcast for the factors impacting this shift, and what it all means for developers, healthcare providers, and patients.
Report December 12, 2019
Listen to our podcast with Jessica Shull, European Lead for the Digital Therapeutics Alliance, an international non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics.
Report December 11, 2019
Digital therapeutics have been hailed as a game-changer for pharma and patients, but are they keeping up with the hype? Pharmaphorum caught up with the Syneos Health team, including Skye Hodson, Alex Brock and Duncan Arbour, to discuss their experience.
Report December 11, 2019
Improving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new innovations at their disposal, along with a sincere commitment to patient centricity, the industry still struggles to get patients engaged with trials.
Report December 9, 2019
The Biggest Shifts Changing Lives and Life Sciences
Report December 4, 2019
Catch Meg Alexander, Head, Reputation & Risk Management Practice at Syneos Health, on RARECast - a podcast focused on the intersection of rare disease with business, science, and policy.
Report November 22, 2019
Translating caregiver insights into marketing action. Part of our Caregiver Insights Series.
Report November 21, 2019
Drug developers and regulators are expanding the use of real world evidence to design, test and review rare disease treatments. But market access challenges persist as payers in the U.S. and Europe continue to express doubts. Our new survey sheds light on the perception gap.
Report November 5, 2019
Is Europe catching up (or pioneering the way) in digital therapeutics?
Report November 1, 2019
In just the past five years, significant changes have occurred in how new drugs come to market. Demands for real world evidence and patient-reported outcomes are changing how and when new drugs file for approval.
Report October 31, 2019
Patient advocacy has evolved over time, and with it, patient advocate archetypes have emerged. Listen and learn about the five types of advocates (the Caregiver, the Creator, the Citizen, the Magician, and the Rebel).
Report October 15, 2019
In this PharmaTimes article, Duncan Arbour, SVP Innovation at Syneos Health Communications Europe, talks about the need for being faster to what really matters and finding the right protocols for patients.
Report September 30, 2019
In this book, we teamed up a behavioral scientist and a healthcare communicator to work together to create one clear picture of what we know and how we can apply it in the everyday work of helping more people live healthier lives.
Report September 25, 2019
Why do people make good (and bad) decisions about their health? How can we help motivate them to change and give them the resilience to try and try again? Our industry and our world are obsessed with those questions right now.
Report September 25, 2019
To help our pharma clients elevate customer relationships, we created a dedicated assessment methodology to define a multi-dimensional measure of trust. Learn how it can be used to establish more effective customer communication in this PMLiVE article.
Report September 17, 2019
In this guest blog, Keri Mcdonough, Lead, Advocacy and Patient Relations at Syneos Health Communications shares her insight on how to assemble a patient advisory board that accurately and effectively represents the patient voice.
Report September 13, 2019
Despite parallel efforts by biopharmaceutical innovators, the demographics of clinical trials today still do not reflect the racial, ethnic or gender diversity of target patient populations around the world.
Report August 16, 2019
PIE – or Preapproval Information Exchange – refers to the communication of clinical and health care economic information on therapies in development between U.S. population health decision makers and drug manufacturers prior to regulatory approval.
Report July 31, 2019
Our team discusses the digital therapeutics landscape, the opportunities for both biopharma and tech companies, regulatory and payer hurdles, and more.
Report July 9, 2019
Coverage can be the entry or roadblock to getting your product into the patient’s hands. The trend toward consolidation means there are fewer opportunities for pharma brands to tell their story and demonstrate their product’s value.
Report June 10, 2019
The biopharmaceutical market has evolved quite a bit over the last five to 10 years. As more emerging companies are opting to commercialize on their own, they can no longer look to the “tried and true,” traditional strategies for bringing a therapy to market.
Report June 3, 2019
Year after year, you think it can't possibly be happening again already, but the five original and eight revised calendar invites don't lie: it's time for brand planning! What if there was a better way? At Syneos Health Communications, we think there is.
Report May 6, 2019
All signs point to a breakthrough year for digital therapeutics. With the market poised to hit half a billion U.S. dollars by 2021, the industry is approaching an inflection point. Read our new report - How Digital Therapeutics Developers Can Satisfy Diverse Stakeholder Need
Report April 18, 2019
Amy Hutnik, Chief Growth and Transformation Officer for Syneos Health Communications, discusses how communications intelligence and channels have evolved with the availability of data.
Report April 15, 2019
Agile work models and design thinking have sped up innovation in IT, manufacturing and retail. Now, the movement is transforming life sciences.
Report March 13, 2019
Healthcare complexity is reshaping the very nature of field teams. In our latest guide, Field Force Forecast, we lay out why our field force needs to transition from a focus on selling to a focus on removing hurdles. Download to learn more.
Report February 11, 2019
The Harris Poll conducted an online survey among 302 Primary Care Physicians in the U.S. on behalf of GSW, a Syneos Health company. The research revealed that 76% of doctors prefer simple language in advertising. Download the full survey results to learn more.
Report February 6, 2019
Learn how to co-create with your customers to uncover better real world solutions in advisory boards.
Report January 30, 2019
We identified 40 microstrategies brands are using today to connect with people in innovative and unexpected ways.
Report January 8, 2019
What healthcare stakeholders should think about when it comes to DTx partnerships and how DTx developers can satisfy diverse stakeholder needs.
Report December 17, 2018
It’s just one word. But it carries the weight of over 43 million people, about a quarter which spends 41 hours or more per week providing care for loved ones with medical conditions.
Report November 28, 2018
Latest report highlights 5 lessons on reaching caregivers and patients with relevant and resonant messaging.
Report November 28, 2018
After surveying 515 American consumers to understand how they are engaging with their healthcare, we uncovered the presence of two health mindsets: invested individualists and disaffected communitarians. Read more in our latest report.
Report November 27, 2018
In today’s dynamic landscape, life science leaders don’t need more data; they need decision-driving insights to be able to act and invest with confidence. The 2019 Health Trend Ten from Syneos Health dives deep into challenges and opportunities in the year ahead.
Report October 31, 2018
In our increasingly digital world, it was only a matter of time before search and social marketing would start to take on an important role in clinical trial patient recruitment.
Report October 22, 2018
Clinical educators can help empower the patient to make their own informed healthcare choices.
Report October 22, 2018
Caregivers are an integral part of care teams and are involved in everything from medication choices to adherence strategies. Yet, even as life sciences companies focus on patient centricity, caregivers have often been left out of the conversation.
Report October 15, 2018
Increasingly, search and social marketing have taken on an important role in clinical trial patient recruitment. In September 2018, we surveyed 432 potential clinical trial participants in the United States.
Report July 30, 2018
Decision-making increasingly relies on data, which comes at us with such overwhelming velocity, and in such volume, that we can’t comprehend it without some layer of abstraction, such as a visual one.
Report July 10, 2018
Keri McDonough, our communications and advocacy relations strategist, lays out our top 10 recommendations for meaningful patient advocacy group engagement on the runway to launch and beyond.
Report June 19, 2018
Chamberlain Healthcare PR, a Syneos Health company, lays out five key insights on how to break through the clutter at ASCO.
Report June 12, 2018
We surveyed 150 European and American patients with breast cancer to better understand their perspectives about the potential role of AI in healthcare.
Report June 7, 2018
We’ve pulled together for you all our best thinking from our Reputation & Risk Management team - comprised of healthcare communicators, policy-shapers and crisis response specialists.
Report June 4, 2018
Key Factors Shaping the U.S. Market Landscape for Rare Diseases
Report May 8, 2018
Christie Anbar, Managing Director of Chamberlain Healthcare PR, Syneos Health, participated in a recent MM&M TrendTalks roundtable focused on “spend and trends” in the areas of healthcare professional (HCP), patient and payer marketing.
Report April 26, 2018
Curious how the Institute for Clinical and Economic Review works?
Report February 21, 2018
Since Stanley Kubrick's 2001: A Space Odyssey introduced the prospect of Artificial Intelligence (AI) with the spaceship computer system HAL, the world has had a rollercoaster relationship with the idea - from hope to hype, and everywhere in between.
Report January 29, 2018
Over 2017, Artificial Intelligence became a mainstream topic of conversation, with industry, investors and the media discussing its possible impact on all areas of our personal and professional lives.
Report January 2, 2018
Trends show us the latest customer expectations, and reveal data and clues about changing habits and preferences. Healthcare marketers can use trends to challenge how they go to market and to continually innovate every aspect of what they provide to consumers.
Report January 2, 2018
Shifts in how brands are earning time, attention and loyalty
Report January 2, 2018
Expectations created by media, peers and entertainment
Report January 2, 2018
New realities in accessing, giving and receiving healthcare
Report January 2, 2018
Behavior changes influenced by technology, tools and devices
Report January 2, 2018
Trends show us the latest customer expectations, and reveal data and clues about changing habits and preferences. Healthcare marketers can use trends to challenge how they go to market and to continually innovate every aspect of what they provide to consumers.
Report January 2, 2018
Rewired commercial model evolving from every point of influence in health and healthcare
Report December 27, 2017
Health insurers have raised challenging questions about how drugs for rare diseases are defined, regulated, and priced in the U.S. market. To learn more...
Report December 22, 2017
A recent survey of pharmaceutical execs found that 84% believe that innovation is imperative to reaching their business goals but 0% strongly agree they know where to start.
Report September 12, 2017
There has never been a better time to talk about Voice. Last year, Gartner predicted that by 2020 the average person would be having more conversations with virtual bots and assistants than with their spouse.
Report August 10, 2017
Our PR Group is just back from Strengthening Patient Advocacy Relations Conference where Meg Alexander, Head, Reputation & Risk Management & Chris Iafolla, Head, Digital & Social Strategy, presented “Worlds Colliding: When Patient Activism Meets Pharma’s Digital Channels".
Report June 15, 2017
With a room full of world-class creatives at Cannes, we explored the hallmarks of social-centric programs and how good creative must work within each person’s social system.
Report June 6, 2017
In more than 15 hours of interviews, executives at managed care organizations covering more than 59 million lives talked about issues that are top of mind for mental health patients, including medication access and psychiatric care.
Report May 17, 2017
Patient-centricity is an individualistic approach. But, in real life, individual behavior is strongly influenced by context. By highlighting the social influences that impact patient behavior, we can identify forces that directly conflict with behavior we want to promote.
Report May 16, 2017
The pharmaceutical industry recognizes that consumer behavior is a key to both better individual health outcomes and greater business success, and has created a wide range of programs to engage and support patients who are taking prescribed medication.
Report May 15, 2017
More than 8 out of 10 pharmaceutical marketers agree that innovation is imperative to reaching their business goals, yet none of them strongly agree that they know on which touchpoints, channels or customer experiences to focus change.
Report May 13, 2017
Major disrupters in the pharmaceutical industry have put the spotlight on quantifying value and measuring impact. The appetite for innovation and change is strong. But the tolerance for risk is not. Business leaders want to understand the return on new investments...
Report May 13, 2017
As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis.
Report May 10, 2017
New research from GSW, Syneos Health PR Group and PALIO indicates that millennial physicians are redefining the patient-physician relationship.
Report May 9, 2017
At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases.
Report May 8, 2017
Since the fall of 2015, and against a backdrop of harsh media attention to pharmaceutical pricing, patient advocacy groups that form partnerships with pharma companies have received negative coverage in The New York Times, USA Today and other publications.
Report May 7, 2017
Social media offers incredible power to engage stakeholders, but also gives exposure to those who don’t agree with you or seek change. Companies must never be dissuaded from engagement with all audiences.
Report May 5, 2017
What do millennial adults want from healthcare? Research from GSW, Allidura and Harris Poll reveals their changing expectations–and the brands already meeting them.
Report May 4, 2017
Noticing important shifts in the rules of engagement between industry and patient advocates, Syneos Health Public Relations Group conducted in-depth interviews with dozens of patient organizations in early 2015.
Report May 3, 2017
Dramatic changes in U.S. healthcare over the last few years have forced a rethinking of the partnerships pharmaceutical companies form with groups representing patients and families.
Report May 2, 2017
A recent study by Allidura Consumer, GSW and Harris Poll finds that adult millennials highly value happiness, but there appears to be a big tension between their aspirations for happiness–97% say it’s important–and the well-documented way millennials are currently living.
Report May 1, 2017
Data and predictive analytics are rapidly evolving how we target customers and develop integrated communications plans that flow seamlessly across channels. Today it’s possible to pinpoint exactly where to find your most likely customers
Report May 1, 2017
The Web is littered with examples of the public decrying corporate missteps. “You didn’t protect my baby.” “Why does your drink contain carcinogens?” “You’re denying cancer patients a life-saving drug!”
Report May 2, 2016
Understanding how people’s expectations are changing allows companies to capture new market opportunities, take smart risks and spur innovation.
Report November 2, 2015
An AI wave is poised to transform healthcare with examples ranging from supercomputers identifying hard-to-diagnose cancers; robots assisting surgeons with complex procedures; and chatbot therapists supporting patients with cognitive behavioural therapy.
Report January 14, 2015
We’ve pulled together for you all our best thinking on 2018 trends, artificial intelligence and driving forward healthcare democracy.
Already have a RSS feed reader?
